Profil
Robert I.
Taber is the founder.
In 1998, he founded Message Pharmaceuticals, Inc. as a Director.
He also held former positions as Director-Biological Research at Schering Corp.
in 1982, Director at Palatin Technologies, Inc. from 2001 to 2011, Senior Vice President-Research & Development at Lundbeck Research USA, Inc. from 1994 to 1998, and Vice President-Extramural Research & Development at DuPont Merck Pharmaceutical Co. He earned a doctorate degree from the Medical College of Virginia.
Ehemalige bekannte Positionen von Robert Taber
| Unternehmen | Position | Ende |
|---|---|---|
Message Pharmaceuticals, Inc.
Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Gründer | 10.10.2008 |
Lundbeck Research USA, Inc.
Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 |
Schering Corp.
Schering Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1982 |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Technik-/Wissenschafts-/F&E-Leiter | - |
| PALATIN TECHNOLOGIES, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Robert Taber
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Schering Corp.
Schering Corp. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Lundbeck Research USA, Inc.
Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
Palatin Technologies, Inc.
Palatin Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops medicines based on molecules for the modulation of melanocortin receptor system | Health Technology |
DuPont Merck Pharmaceutical Co.
DuPont Merck Pharmaceutical Co. Pharmaceuticals: MajorHealth Technology Makes pharmaceuticals and drugs | Health Technology |
Medical College of Virginia
Medical College of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Message Pharmaceuticals, Inc.
Message Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical drugs | Health Technology |
















